BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2011

Oct 11, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2011-10-10

Reporting Person: ABERCROMBIE GEORGE B (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-10-10	Non-Qualified Stock Option	$2.63	A	16667	Acquired	2021-10-10	Common Stock (16667)	Direct

Footnotes

F1: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan (the "Plan").

F2: The option vests 1/8 per month for a period of 8 months, beginning on October 10, 2011.